	Durvalumab Consolidation After Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Efficacy and Safety. Am J Clin Oncol Musheer A, Mannan MS, Khan MW, Junaid A, Basit T, Hafeez AS, Shahzad M. PMID: 42574292 [PubMed - as supplied by publisher]
	Rilvegostomig for Metastatic Non-Small-Cell Lung Cancer: A First-In-Human Phase I/II Clinical Study. Clin Cancer Res Rohrberg KS, Brandão M, Castañón Álvarez E, Felip E, Gort E, Hiltermann TJN, Izumi H, Kim DW, Kim SW, Paz-Ares L, Solomon B, Smit EF, Wauters E, Yoshida T, Ayyoub A, Chen HA, Colebrook S, Hamidi NN, Kuziora M, Lim K, Achour I, Drachsler MW, Karanovic D, Liu N, Cho BC. PMID: 42574065 [PubMed - as supplied by publisher]
	Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial. JAMA Zhou T, Zhou H, Gao F, Feng W, Jiang W, Huang L, Zhao F, Chen L, Ji M, Zhu J, Fang Y, Chen P, Wang P, Wu J, Zhuang L, Liu X, Deng M, Weng G, Li J, Yang C, Zhao H, Yang Y, Zhang L. PMID: 42574006 [PubMed - as supplied by publisher]
	Health Communication and Stepped Reminders Interventions for Lung Cancer Screening: A Randomized Clinical Trial. JAMA Intern Med Wernli KJ, Anderson ML, Palazzo L, Luce C, Bezman N, Rogers K, Chin M, Gao H, Ralston J, Su YR, Carter-Bawa L, Triplette M, Tuzzio L, Vasavada A, Green BB. PMID: 42574003 [PubMed - as supplied by publisher]
	Heat shock protein family D member 1 (HSPD1) modulates ribosome-related pathways and protein synthesis in lung adenocarcinoma. Mol Cell Biochem Somsuan K, Rongjumnong A, Chiangjong W, Ngoenkam J, Morchang A, Karamart P, Panachan J, Kaewboonruang P, Mongkolwat W, Chutipongtanate S, Pongcharoen S, Berghe WV, Aluksanasuwan S. PMID: 42573975 [PubMed - as supplied by publisher]
	Interstitial lung disease in metastatic breast cancer: a landscape review using SEER-Medicare. Breast Cancer Res Treat Pinheiro LC, An A, Landry CA, Tonorezos E, Aronson KI. PMID: 42573635 [PubMed - indexed for MEDLINE]
	Efficacy of Chest Radiograph in Comparison to no Intervention in Screening for Lung Cancer in People who Smoke: A Systematic Review. Ann Afr Med Singh P, Singh BP, Verma UP, Verma AK, Parihar A, Kirubakaran R. PMID: 42573570 [PubMed - as supplied by publisher]
	ACR Appropriateness CriteriaÂ® Indolent Lung Cancer. J Am Coll Radiol Expert Panel on Thoracic Imaging, Digumarthy SR, Messick B, Walker CM, Little BP, Amini A, Batra K, Begnaud A, Brixey AG, Carroll MB, Chelala L, Christensen JD, Cox CW, Kim RY, Lin K, Lui NS, Nagji AS, Puri S, Stowell JT, Ulaner GA, Yanagawa J, Henry TS. PMID: 42573542 [PubMed - as supplied by publisher]
	Triple-Component Lung Carcinoma Diagnosed After Nondiagnostic EBUS: A Case Report. Cureus Le W, Tirupathi M, Oh L, Diaz M, Tirupathi S. PMID: 42572645 [PubMed]
	Bilateral Blindness Due to Radiation-Induced Optic Neuropathy in a Patient with Nasal Mucosal Melanoma. Rom J Ophthalmol Benetti MA, León-Cejas L, Miquelini LA, Ribero-Ayerza D, Caiza-Zambrano F, Reisin R. PMID: 42572628 [PubMed - indexed for MEDLINE]
	A Data-Driven Atlas of CAR-Based Immunotherapy in Lung Cancer: Insights from Multidatabase Integration. Pharmacol Res He F, Zhu X, Wang X, Ju X, Wu F, Di W, Su S, Huang H. PMID: 42571830 [PubMed - as supplied by publisher]
	Efficacy and Safety of Sintilimab in Combination With Anlotinib and Chemoradiotherapy as First-Line Treatment for Driver Gene-Negative Oligometastatic Non-small Cell Lung Cancer: A Real-World Cohort Study. Dose Response Jiang J, Ni C, Wu C, Song Y, Zhu H. PMID: 42571169 [PubMed]
	Clinical characteristics of lung cancer in never-smokers: a multicenter Saudi cohort. Ann Saudi Med Ternati M, Qashqari A, Alshelli I, Alrasheed S, Ahmed L, Sagar AES. PMID: 42571038 [PubMed - indexed for MEDLINE]
	Lung Cancer Patient Advocacy Progress and New Challenges Since 2006. J Thorac Oncol Pujol JL, Roy UB, Feldman J, Egwuenu C. PMID: 42552032 [PubMed - indexed for MEDLINE]
	Single-cell study reveals early alterations in peripheral blood immune responses at day 7 following microwave ablation for lung cancer. Cell Immunol Wu Y, Wei X, Yang W, Wang F, Wang J, Huang Z, Zou F, Liu J. PMID: 42551135 [PubMed - as supplied by publisher]
	Geographic Access to Low-Dose CT Lung Cancer Screening in Tennessee: Disparities by Socioeconomic Variables, Rurality, and Appalachian Status. J Rural Health Namin S, Whiteside M, Heidel RE, Wall JS, Ferris J, Dhand R. PMID: 42569835 [PubMed - indexed for MEDLINE]
	Real-World Outcomes of Consolidation Durvalumab After Chemoradiotherapy in Unresectable Stage III Non-Small Cell Lung Cancer: A Retrospective Cohort Study From Vietnam. Asia Pac J Clin Oncol Tran HT, Do KH, Nguyen HTT, Nguyen HTN, Nguyen PTB, Dao TM, Van Nguyen T, Nguyen TA, Doan HN, Hoang NB. PMID: 42569796 [PubMed - as supplied by publisher]
	Prognostic and Predictive Value of Peripheral CD8/PD-1/TCF-1 Positive T Cells in Non-Small Cell Lung Carcinoma Patients. Immunotargets Ther Xagara A, Goulielmaki M, Chantzara E, Koinis F, Fortis SP, Hatzidaki D, Ntostoglou K, Christodoulopoulos G, Saloustros E, Karagiannis SN, Frisan T, Baxevanis CN, Georgoulias V, Pateras IS, Kotsakis A. PMID: 42569581 [PubMed]
	Metal Nanoparticles as Sensitizers in Energy-Based Therapies for Lung Cancer: From Mechanistic Insights to Clinical Translation. Int J Nanomedicine Jin X, Li Y, Zhang R, Yang Y, Han A, Jin X, Zhang S, Quan C, Lin Z, Lin X. PMID: 42569506 [PubMed - indexed for MEDLINE]
	The effect of motivational interviewing on smoking cessation intention in patients with lung cancer: A randomized controlled trial. Tob Induc Dis Dogru S, Aytaç S, Ovayolu Ö. PMID: 42569500 [PubMed]

Articles 1 - 20 / 162134

Page 1 of 8107



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy